DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
1 other identifier
observational
99
1 country
1
Brief Summary
The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 6, 2013
CompletedFirst Posted
Study publicly available on registry
June 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedDecember 19, 2016
December 1, 2016
1.4 years
June 6, 2013
December 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
TV negative by PCR, post treatment
Women are assessed for TV at each weekly visit by PCR. They are considered cleared of the remnant DNA after PCR is negative.
4 weeks
Study Arms (1)
TV postive women
All women who are TV positive by wet prep or in-pouch and meet the inclusion exclusion requirements.
Eligibility Criteria
English speaking HIV- women over the age of 18 who are TV positive
You may qualify if:
- English speaking females
- \>18 years old
- HIV-negative
- a patient at the Delgado Personal Health Center
You may not qualify if:
- HIV+ women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Delgado Personal Health Center
New Orleans, Louisiana, 70112, United States
Biospecimen
1 vaginal swab collected at screening for In-pouch 3 vaginal swabs collected at enrollment, PCR, gram stain, and future microbiome study At each of 3 follow-up visits, 3 vaginal swabs, PCR, In-pouch, and future microbiome study At the 4th follow-up visit, 4 vaginal swabs, PCR, In-pouch, gram stain, and future microbiome study. All swabs, except at screening, are self-collected.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia J Kissinger, PhD
Tulane University School of Public Health and Tropical Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 6, 2013
First Posted
June 10, 2013
Study Start
November 1, 2012
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
December 19, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share